Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Journal of Clinical Microbiology|December 2, 2016
Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in BelarusKurt R Wollenberg, Christopher A Desjardins, Aksana Zalutskaya, et al.Mbio|October 23, 2014
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter studyPaolo Miotto, Andrea M Cabibbe, Silke Feuerriegel, et al.Science (New York, N.Y.)|December 14, 2004
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosisKoen Andries, Peter Verhasselt, Jerome Guillemont, et al.BMJ Open|October 6, 2018
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort studyLina Davies Forsman, Katarina Niward, Yi Hu, et al.Antimicrobial Agents and Chemotherapy|October 16, 2013
Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosisShahul Hameed P, Suresh Solapure, Kakoli Mukherjee, et al.Scientific Reports|February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.Scientific Reports|October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.The Lancet. Infectious Diseases|July 12, 2016
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance projectMatteo Zignol, Anna S Dean, Natavan Alikhanova, et al.The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.Journal of Medicinal Chemistry|May 10, 2014
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosisShahul Hameed P, Vikas Patil, Suresh Solapure, et al.Pageof 11